Innovent, Takeda ink up to US$ 11.4 bn oncology deal; FDA clears Novo’s Rybelsus to reduce heart risk in diabetics
In this week’s Phispers, China’s Innovent Biologics signed one of the largest cross-border biotech deals in Asia. U...
Impressions : 1561

